News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
211,414 Results
Type
Article (7179)
Company Profile (38)
Press Release (204197)
Section
Business (55667)
Career Advice (173)
Deals (10653)
Drug Delivery (45)
Drug Development (12611)
Employer Resources (35)
FDA (5816)
Job Trends (5365)
News (87321)
Policy (8672)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
Academia (707)
Accelerated approval (1)
Adcomms (1)
Allergies (31)
Alliances (15296)
ALS (11)
Alzheimer's disease (328)
Antibody-drug conjugate (ADC) (21)
Approvals (5871)
Artificial intelligence (144)
Autoimmune disease (4)
Automation (3)
Bankruptcy (67)
Best Places to Work (4882)
BIOSECURE Act (4)
Biosimilars (51)
Biotechnology (18)
Bladder cancer (21)
Brain cancer (3)
Breast cancer (90)
Cancer (534)
Cardiovascular disease (63)
Career advice (165)
Career pathing (1)
CAR-T (20)
Cell therapy (81)
Cervical cancer (7)
Clinical research (10761)
Collaboration (277)
Compensation (22)
Complete response letters (2)
COVID-19 (735)
CRISPR (11)
C-suite (93)
Cystic fibrosis (19)
Data (612)
Decentralized trials (1)
Denatured (9)
Depression (12)
Diabetes (85)
Diagnostics (3209)
Digital health (11)
Diversity (3)
Diversity, equity & inclusion (11)
Drug discovery (33)
Drug pricing (46)
Drug shortages (6)
Duchenne muscular dystrophy (30)
Earnings (17941)
Editorial (14)
Employer branding (1)
Employer resources (31)
Events (48169)
Executive appointments (282)
FDA (6259)
Featured Employer (10)
Frontotemporal dementia (3)
Funding (255)
Gene editing (24)
Generative AI (16)
Gene therapy (67)
GLP-1 (171)
Government (1353)
Grass and pollen (2)
Guidances (25)
Healthcare (8622)
Huntington's disease (2)
IgA nephropathy (11)
Immunology and inflammation (18)
Indications (12)
Infectious disease (784)
Inflammatory bowel disease (38)
Inflation Reduction Act (5)
Influenza (13)
Intellectual property (19)
Interviews (15)
IPO (4303)
IRA (16)
Job creations (711)
Job search strategy (154)
Kidney cancer (1)
Labor market (3)
Layoffs (76)
Legal (1653)
Liver cancer (17)
Lung cancer (73)
Lymphoma (34)
Machine learning (2)
Management (14)
Manufacturing (70)
MASH (19)
Medical device (6154)
Medtech (6154)
Mergers & acquisitions (6597)
Metabolic disorders (218)
Multiple sclerosis (33)
NASH (5)
Neurodegenerative disease (17)
Neuropsychiatric disorders (6)
Neuroscience (445)
NextGen: Class of 2025 (2902)
Non-profit (1544)
Northern California (762)
Now hiring (2)
Obesity (119)
Opinion (65)
Ovarian cancer (14)
Pain (19)
Pancreatic cancer (14)
Parkinson's disease (21)
Partnered (7)
Patents (35)
Patient recruitment (31)
Peanut (19)
People (18570)
Pharmaceutical (12)
Pharmacy benefit managers (8)
Phase I (2272)
Phase II (3796)
Phase III (5132)
Pipeline (356)
Podcasts (23)
Policy (41)
Postmarket research (741)
Preclinical (719)
Press Release (10)
Prostate cancer (35)
Psychedelics (5)
Radiopharmaceuticals (76)
Rare diseases (103)
Real estate (1405)
Recruiting (11)
Regulatory (6317)
Reports (16)
Research institute (629)
Resumes & cover letters (13)
Rett syndrome (3)
RNA editing (1)
RSV (16)
Schizophrenia (17)
Series A (40)
Series B (37)
Service/supplier (3)
Sickle cell disease (25)
Southern California (626)
Special edition (6)
Spinal muscular atrophy (35)
Sponsored (6)
Startups (1232)
Stomach cancer (2)
Supply chain (22)
Tariffs (3)
The Weekly (14)
United States (7357)
Vaccines (148)
Venture capitalists (16)
Webinars (4)
Weight loss (61)
Women's health (20)
Worklife (2)
Date
Today (25)
Last 7 days (268)
Last 30 days (908)
Last 365 days (11778)
2025 (3365)
2024 (11964)
2023 (13104)
2022 (20290)
2021 (21611)
2020 (20950)
2019 (17798)
2018 (13174)
2017 (9056)
2016 (9626)
2015 (11055)
2014 (8167)
2013 (6727)
2012 (7024)
2011 (6996)
2010 (5626)
Location
Africa (231)
Alabama (13)
Alaska (1)
Arizona (65)
Arkansas (6)
Asia (11004)
Australia (1476)
California (1686)
Canada (590)
China (155)
Colorado (112)
Connecticut (80)
Delaware (44)
Europe (26667)
Florida (297)
Georgia (88)
Hawaii (1)
Idaho (18)
Illinois (216)
India (16)
Indiana (133)
Iowa (1)
Japan (74)
Kansas (23)
Kentucky (13)
Louisiana (7)
Maine (26)
Maryland (218)
Massachusetts (1374)
Michigan (86)
Minnesota (127)
Mississippi (2)
Missouri (53)
Montana (5)
Nebraska (13)
Nevada (15)
New Hampshire (24)
New Jersey (646)
New Mexico (7)
New York (582)
North Carolina (393)
North Dakota (1)
Northern California (762)
Ohio (62)
Oklahoma (6)
Oregon (11)
Pennsylvania (487)
Puerto Rico (3)
Rhode Island (7)
South America (308)
South Carolina (8)
Southern California (626)
Tennessee (66)
Texas (241)
Utah (95)
Virginia (38)
Washington D.C. (25)
Washington State (141)
West Virginia (3)
Wisconsin (23)
211,414 Results for "gns healthcare".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Annual General Meeting 2025 – GN Store Nord A/S
March 13, 2025
·
3 min read
Drug Development
GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis
September 25, 2024
·
2 min read
Business
GNS Appoints John Maraganore, PhD, as Strategic Advisor
GNS today announced that John Maraganore, PhD, biopharma industry leader and the former founding CEO of Alnylam Pharmaceuticals, has joined GNS as a strategic advisor.
June 9, 2022
·
3 min read
Genetown
GNS Healthcare and Scipher Medicine® Collaborate to Develop World’s First in silico Patient for Rheumatoid Arthritis
GNS Healthcare and Scipher Medicine ® Collaborate to Develop World’s First in silico Patient for Rheumatoid Arthritis
November 4, 2021
·
4 min read
GN expands groundbreaking ReSound OMNIA family enabling more people to hear their best in noise
GN Hearing, the global leader in hearing aid innovation, announces the expansion of the popular ReSound OMNIA family, providing more options to address the biggest unmet need for people with hearing loss: hearing speech in noisy environments.
February 7, 2023
·
4 min read
Press Releases
electroCore to Participate at the Needham Virtual Healthcare Conference
April 1, 2025
·
1 min read
Business
GNS Healthcare Announces a Multi-Year Collaboration with a Leading US Cancer Center to Advance Precision Medicine in Oncology
GNS Healthcare (GNS), an artificial intelligence company creating in silico patients that simulate drug treatment at the individual patient level, today announced a multi-year collaboration with Memorial Sloan Kettering Cancer Center (MSK) to leverage longitudinal multi-modal prostate cancer patient data and world class prostate cancer expertise with GNS’ Gemini in silico Prostate Cancer patient.
October 5, 2021
·
3 min read
Press Releases
Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March
March 3, 2025
·
2 min read
Press Releases
Boundless Bio to Participate in the Needham Virtual Healthcare Conference
April 3, 2025
·
1 min read
Press Releases
Curis to Present at Upcoming Healthcare Conference in April 2025
April 3, 2025
·
1 min read
1 of 21,142
Next
